Last reviewed · How we verify

NCT03814473

Paleo Diet 8wk Feasibility in Overweight Adults

Completed NA Last updated 24 January 2019
What this trial tests

NA trial testing Diet in Overweight and Obesity in 21 participants. Completed in 14 April 2015.

Timeline
19 January 2015
Primary endpoint
14 April 2015
14 April 2015

Quick facts

Lead sponsorUniversity of Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment21
Start date19 January 2015
Primary completion14 April 2015
Estimated completion14 April 2015
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Houston

Who can join

Adults 18 to 55, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overweight, physically inactive but otherwise healthy adults habitually eating a traditional Western diet will follow an ad libitum self-administered Paleo diet for 8-weeks. Blood and body composition will be measured before and after the intervention period.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Single-Arm 8-Week Ad Libitum Self-Prepared Paleo Diet Reduces Cardiometabolic Disease Risk Factors in Overweight Adults.
    Markofski MM, Jennings K, Dolan C, Davies NA, et al · · 2021 · cited 5× · PMID 34916890 · DOI 10.1177/1559827619866157

Verify or expand the search:

Other trials of Diet

Trials testing the same drug.

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

Other University of Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing